Dermatology pharmaceutical company, Galderma, has announced a US nationwide collaboration with aesthetic medicine company best know for breast aesthetics and reconstruction, Mentor Worldwide LLC.
Galderma and Mentor will provide a range of offerings to healthcare professionals in the US who may have shared patients looking for aesthetic injectable treatments and breast enhancement.
According to Galderma, data indicates up to 33% of women in the US who have injectable treatments also have breast augmentation.
Vice president and general manager at the aesthetic and corrective business unit at Galderma US, Kelly Huang, said, "This collaboration with Mentor demonstrates our commitment to being the partner of choice within the aesthetics industry and furthers our goal of providing long-term value to healthcare specialists while broadening consumers' access to and awareness of their aesthetic treatment options."
The partnership will involve surgeons from each company collaborating together to raise patient experience across the companies’ aesthetic and corrective brands including Galderma’s Restylane and Dysport, along with Mentor’s MemoryShape, MemoryGel and Breast Implants portfolio.